Twist Bioscience Corp (NAS:TWST)
$ 42.23 0.87 (2.1%) Market Cap: 2.46 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 4.38 GF Score: 83/100

Twist Bioscience Corp at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 01:15AM GMT
Release Date Price: $26 (+5.48%)
Casey Rene Woodring
JPMorgan Chase & Co, Research Division - Research Analyst

Hi, everybody. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPM. Pleased to introduce our next company, Twist Bioscience, joined here by the management team. We will be doing a brief presentation and then a Q&A afterwards. And so now without further ado, CEO, Emily Leproust.

Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, Chairman & CEO

Thank you very much for the invitation and the introduction. It's a great pleasure to be here. I'll start by saying that today, I'll be making some forward-looking statements.

And so at Twist, as you know, we have a platform to write DNA, and we have enabled a large number of applications shown on the screen. And beyond DNA, once you've made the DNA, you're halfway there to get to the RNA and then you're almost there to make to the protein. And so we are expanding our product line into RNA and proteins.

And really, there's 3 things to remember for today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot